Key facts
- This page summarizes Christopher Simon's Form 4 filing for HAEMONETICS CORP (HAE).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Jun 2024, 16:15.
Christopher Simon - 06 Jun 2024 Form 4 Insider Report for HAEMONETICS CORP (HAE)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- HAE
- Reported as of
- 06 Jun 2024
- Net transaction value
- -$1,881,206
- SEC form
- 4
- Accepted by SEC
- 07 Jun 2024, 16:15:03 UTC
- Prior SEC filing
- 29 May 2024
- Next SEC filing
- 09 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher Simon filed Form 4 for HAEMONETICS CORP (HAE) on 07 Jun 2024.
Change
- Previous filing in this sequence was filed on 29 May 2024.
- Current net transaction value: -$1,881,206.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HAE
transaction
Common Stock
Options Exercise
- Transaction value
- $4,352,046
- Shares
- +104,516
- Change %
- +32%
- Price
- $41.64
- Shares after
- 433,877
- Date
- 06 Jun 2024
- Ownership
- Direct
- Footnotes
- F1, F2
HAE
transaction
Common Stock
Tax liability
- Transaction value
- $6,233,252
- Shares
- -71,335
- Change %
- -16%
- Price
- $87.38
- Shares after
- 362,542
- Date
- 06 Jun 2024
- Ownership
- Direct
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HAE
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -104,516
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 06 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 104,516
- Exercise price
- $41.64
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents an automatic exercise of options granted in 2017 and scheduled to expire after June 6, 2024, as reflected in this Form 4.
Footnote F2
This number includes unvested restricted stock units previously reported.
Footnote F3
Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
Footnote F4
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.